Impact Factor
4.61
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
15.96
4,247 total citations
h5-index
97
h5 depth signal
Cited share
68.2%
193 of 283
Total citations
4,247
Citation footprint
Metric signal
17.08
External metric anchor
Self-citation
0.4%
17 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
421
United Kingdom
223
Germany
141
Australia
95
Italy
95
Citing Fields of Research
Neurodegenerative Disorders
663
Neuromuscular Disorders
260
Brain Neurological Disorders
209
Neurosciences
162
Nervous System Disorders
136
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
3,466
Articles tracked across the journal lifetime
Indexed publication set
283
193 cited publications
Last 12 months
127
10.6 publications/month
Open access share
1.6%
2 OA publications in the last year
Leading citing country
United States
421 citing publications
Leading citing field
Neurodegenerative Disorders
663 citing publications
Latest tracked publication
19 October 2026
10 recent records available
Coverage & Indexing History
v5n4, Apr. 2009-
v5n4, Apr. 2009-
Research Focus & Classification
Indexed Subjects
Neurodegenerative Disorders
Neuromuscular Disorders
Broad Categories
Neurology
Neurodegenerative Disorders
MeSH Descriptors
Nervous System Diseases
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1038/s41582-026-01276-x
Open DOI
Multi-organ imaging genetics: towards an integrated view of brain, body and brain diseases
02
DOI 10.1038/s41582-026-01278-9
Open DOI
Menopause-associated proteomic changes link to brain ageing and dementia risk
03
DOI 10.1038/s41582-026-01280-1
Open DOI
EBV reactivation precedes multiple sclerosis relapse
04
DOI 10.1038/s41582-026-01279-8
Open DOI
Progressive sleep abnormalities precede ALS clinical onset
05
DOI 10.1038/s41582-026-01281-0
Open DOI
Astrocytes support glioblastoma cells via tunnelling nanotubes
06
DOI 10.1038/s41582-026-01270-3
Open DOI
A roadmap towards clinical use of molecular biomarkers in acute ischaemic stroke
07
DOI 10.1038/s41582-026-01262-3
Open DOI
Lysosomal dysfunction in neurodegenerative disease
08
09
DOI 10.1038/s41582-026-01273-0
Open DOI
Rethinking dementia prevention for a continuum of risk
10
DOI 10.1038/s41582-026-01266-z
Open DOI
The emerging role of microbiota in neuro-oncology
Primary and metastatic brain tumours are associated with poor clinical outcomes, largely owing to limited therapeutic advances and an incomplete understanding of brain tumour biology. Increasing evidence suggests that microbial communiti...
Bibliographical & Catalog Notes
Description based on: Vol. 5, no. 4 (Apr. 2009).
Latest issue consulted: Vol. 5, no. 4 (Apr. 2009).
Also issued online.